AI-Controlled Tissue Perfusion Bioreactor for Long-Term Viability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current bioreactor systems for tissue perfusion, such as those used in clinical and research environments, face limitations in maintaining the tumor microenvironment and anatomical accuracy, leading to unreliable data interpretation and lack of effective models for vesicant-induced injury studies.

Innovation Solution

A bioreactor system with an AI module that includes a media reservoir, peristaltic pump, perfusion chamber, and sensors, capable of extended tissue perfusion up to three weeks, using Dulbecco's Modified Eagle Medium with bovine serum albumin to maintain tissue architecture, and employing AI for real-time monitoring and control to ensure optimal conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current bioreactor systems are used for tissue perfusion, then basic perfusion function is provided, but the tumor microenvironment cannot be maintained and anatomical accuracy is lost

Engineering Contradiction:
Improvetumor microenvironment maintenanceVSAvoidbioreactor system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The bioreactor system is divided into distinct functional modules: a perfusion module for fluid delivery, a imaging module for real-time monitoring, a control module with AI algorithms, and a tissue mounting system. This segmentation allows each module to be optimized independently while maintaining the tumor microenvironment, resolving the contradiction between reliability and complexity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

An AI-based control system acts as an intermediary between the various bioreactor components, coordinating perfusion parameters, imaging timing, and environmental controls. This intelligent mediator ensures the tumor microenvironment is maintained without requiring complex manual coordination of all system components.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Duration of action of moving object

If perfusion period is extended for long-term studies, then research value increases, but tissue viability and system stability deteriorate

Engineering Contradiction:
Improveperfusion periodVSAvoidtissue viability
Core Design Contradiction:
Duration of action of moving objectVSReliability

Solution Approach 1:

The system incorporates real-time feedback through integrated imaging that continuously monitors tissue health indicators. AI algorithms analyze these images to detect early signs of tissue stress or degradation, automatically adjusting perfusion parameters to extend viable perfusion period while maintaining tissue viability throughout the experiment.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The bioreactor maintains continuous perfusion with optimized flow rates and media composition throughout the extended experimental period. The system provides uninterrupted nutrient delivery and waste removal, enabling long-term studies (days to weeks) while preserving tissue viability through sustained optimal conditions.

Inventive Principle:
Principle #20Continuity of useful action

3Reliability

If AI control is implemented for real-time monitoring, then operational reliability improves, but system complexity and computational requirements increase

Engineering Contradiction:
Improveoperational reliabilityVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The AI control system operates autonomously, automatically analyzing imaging data, detecting tissue status changes, and adjusting perfusion parameters without human intervention. This self-service capability improves operational reliability while the modular architecture keeps overall system complexity manageable through automated intelligence.

Inventive Principle:
Principle #25Self-service

4Adaptability or versatility

If human tissue samples are used for perfusion studies, then clinical relevance improves, but availability and ethical constraints worsen

Engineering Contradiction:
Improveclinical relevanceVSAvoidsample availability
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The system is designed to accommodate various tissue types including human samples, animal models, and engineered tissues. By preparing the bioreactor with versatile mounting capabilities and compatible perfusion systems in advance, the platform can quickly adapt to different tissue sources, improving clinical relevance while managing sample availability constraints through proactive system preparation.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system provides a reliable, long-term human skin perfusion model that mimics natural drug delivery routes, allowing high-throughput studies, live imaging, and therapeutic applications while minimizing failure risks through AI-controlled operation.

Implementation Method 1

a peristaltic pump for transferring the media

Methodology Applied
Scientific EffectPeristalsis: Peristalsis

Data Source

PatentUS20260000070A1Methods and systems for tissue perfusion
Publication Date: 2026.01.01 UNIV OF PITTSBURGH OF THE COMMONWEALTH SYST OF HIGHER EDUCATION
  • US20260000070A1 patent drawing
  • US20260000070A1 patent drawing
  • US20260000070A1 patent drawing

AI summary

Systems and methods for perfusing the target tissue are provided. The system can include a processor and a bioreactor. The bioreactor includes a media reservoir for storing media, a peristaltic pump for transferring the media, a perfusion chamber for culturing the target tissue with the media, and a plurality of sensors. The perfusion chamber, the peristaltic pump, and the media reservoir are coupled through the tubing. The processor includes an artificial intelligence (AI) module and is configured to generate periodic reports on the metabolic rate of the target tissue through the plurality of sensors and control an operation of the bioreactor for extending a perfusion period.